Purple Biotech (PPBT) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Purple Biotech has announced a $2.8 million registered direct offering of American Depositary Shares, with H.C. Wainwright & Co. serving as the exclusive placement agent. The funds will support the company’s oncology therapeutic candidates and general corporate needs. The offering is expected to close around December 4, 2024, pending customary conditions.
For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.
